To kick off the MS Global Healthcare Conference, onSeptember 14, Risinger and Harrison hosted former FDACommissioner Dr. Scott Gottlieb to discuss COVID vaccines, antibodies, and FDA considerations. Dr. Gottlieb is reasonably confident that one or more COVID vaccines will be successful. He believes the Phase 1 and 2 data published thus far has demonstrated relatively robust immunogenicity and also the…
Just 2 more trading days remain in 2019 and with that we are looking forward to the longest expansion...
The analysis and Research within comes via the monthly Macro-Memo from RBC Capital Wealth Advisors: We have been predicting...
by Paul Christopher, CFA, Head of Global Market Strategy and Gary Schlossberg, Market Strategist Key takeaways We expect that...
What a week it was for the major averages. The meteoric rise would almost have to find perma-bears and...
S&P 500 and QQQ both showed minor weakness late this week, yet failed to do much technical damage. Both...
Fed minutes disappoint with lack of inflation-targeting details or willingness to employ yield curve control. Meanwhile, the recovery is...
If Risk Management is priority #1… Is that Opportunity Risk or is that Downside Risk? The threat from the...
JPM Market Recap
$0.00
JPM Research Note
$0.00
JP Morgan Market Volatility Report
$0.00
MarketWatch.com – Top Stories
